Guideline on Fixed Combinations
Guideline on clinical development of fixed combination medicinal products
Fixed-Dose Combinations Improve Medication Compliance: A Meta-Analysis - The American Journal of Medicine
The European Medicines Agency Clinical Data Website Enables Insights I | OAJCT
Pharmaceutics | Free Full-Text | Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence | HTML
Network-based prediction of drug combinations | Nature Communications
Guideline on clinical development of fixed combination
New Draft EMA-Guideline On Clinical Development Of Fixed Combination Medicines | The National Law Review
OVERVIEW OF COMMENTS RECEIVED ON DRAFT GUIDELINE ON FIXED COMBINATIONS – REV 1
Annex 5 Guidelines for registration of fixed-dose combination medicinal products - PDF Free Download
Adherence to Single-Pill Versus Free-Equivalent Combination Therapy in Hypertension | Hypertension
Guideline on clinical development of fixed combination medicinal products - The IMPT
Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial -
Pharmaceutical application and development of fixed-dose combination: dosage form review | SpringerLink
Frontiers | Trends in Antidiabetic Drug Discovery: FDA Approved Drugs, New Drugs in Clinical Trials and Global Sales
Rings in Clinical Trials and Drugs: Present and Future | Journal of Medicinal Chemistry
Latest hypertension research to inform clinical practice in Asia | Hypertension Research
Fixed-dose combination therapies with and without aspirin for primary prevention of cardiovascular disease: an individual participant data meta-analysis - The Lancet
Regulatory guidelines and preclinical tools to study the biodistribution of RNA therapeutics - ScienceDirect
Guideline on pharmaceutical fixed combination products
Effective drug combinations in breast, colon and pancreatic cancer cells | Nature
EMA Drafts New Clinical Development Guideline for Fixed Dose Combination Drugs | RAPS
Challenges and opportunities to include patient‐centric product design in industrial medicines development to improve therapeutic goals - Timpe - 2020 - British Journal of Clinical Pharmacology - Wiley Online Library
The European Medicines Agency Clinical Data Website Enables Insights I | OAJCT
What you need to know about fixed-dose combinations - NPS MedicineWise
SmPC of fixed combination medicinal products
